Atlas Trials

Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

Clinical trial NCT05294822 · UNKNOWN

Trial details

NCT number
NCT05294822
Sponsor
Shanghai Changzheng Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes
Start date
2019-09-30
Primary completion
2023-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.